Target (CBDY) EBITDA Margin (2016 - 2026)
Target (CBDY) reported EBITDA Margin of 54.67% for Q1 2026, down 4675.0% year-over-year from 1.2% in Q1 2025, and up 36.14% quarter-over-quarter from 85.61% in Q4 2025.
Target (CBDY) EBITDA Margin (2016 - 2026) Analysis & Trends
Target (CBDY) has 10 years of EBITDA Margin data on file, last reported at 54.67% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 54.67%, down 4675.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 57.3% (down 6477.0% YoY), and the FY2025 annual result was 40.08%, down 4713.0% from the prior year.
- EBITDA Margin improved to 54.67% in Q1 2026 per CBDY's latest filing, from 85.61% in the prior quarter.
- Over five years, EBITDA Margin peaked at 97.61% in Q2 2023 and troughed at 110.9% in Q3 2024.
- A 5-year average of 17.93% and a median of 17.77% in 2025 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin jumped 7968 bps in 2022, then sank 11197 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 28.91% in 2022, then tumbled by 121 bps to 6.13% in 2023, then surged by 530 bps to 26.35% in 2024, then sank by 425 bps to 85.61% in 2025, then soared by 36 bps to 54.67% in 2026.
- Business Quant data shows CBDY's EBITDA Margin at 54.67% in Q1 2026, 85.61% in Q4 2025, and 80.67% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Target | - | - | 191,787.00 | -54.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.67% |
| Dec 31, 2025 | -85.61% |
| Sep 30, 2025 | -80.67% |
| Jun 30, 2025 | -33.06% |
| Mar 31, 2025 | -7.93% |
| Dec 31, 2024 | 26.35% |
| Sep 30, 2024 | -110.90% |
| Jun 30, 2024 | 29.72% |
| Mar 31, 2024 | -5.21% |
| Dec 31, 2023 | -6.13% |
| Sep 30, 2023 | -27.61% |
| Jun 30, 2023 | 97.61% |
| Dec 31, 2022 | 28.91% |
| Sep 30, 2022 | -28.24% |
| Jun 30, 2022 | 21.41% |
| Mar 31, 2022 | -50.82% |
| Dec 31, 2021 | -50.77% |
| Mar 31, 2020 | 5,885.01% |
| Mar 31, 2018 | 83,932.70% |
| Dec 31, 2017 | -754,351.65% |